"Établissement à taille humaine avec ses 738 lits, le Centre Hospitalier d’Ardèche Méridionale (CHArMe) propose une offre de soins polyvalente comportant principalement des activités de médecine, de chirurgie et d’obstétrique, d’accueil des urgences / SMUR / UHCD, d’hospitalisation à domicile, de soins de suite et de réadaptation, ainsi qu’un centre de santé, un centre de la vision et des EHPAD. Les deux sites hospitaliers et les deux EHPAD sont répartis entre les communes d'Aubenas et Vals-les bains. Le CHArMe s’inscrit comme l’acteur de santé incontournable en Sud Ardèche, dont il est le principal pôle économique. Avec une activité en augmentation constante, il dessert un bassin de 100 000 habitants, 150 000 en période estivale."

During the past decade, Centre Hospitalier d'Ardeche Meridionale conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Centre Hospitalier d'Ardeche Meridionale" #1 sponsor was "Federation Francophone de Cancerologie Digestive" with 2 trials, followed by "Hoffmann-La Roche" with 2 trials sponsored, "GERCOR - Multidisciplinary Oncology Cooperative Group" with 1 trials sponsored, "Hospices Civils de Lyon" with 1 trials sponsored and "RESCUe - RESeau Cardiologie Urgence / RESUVal - RESeau des Urgences de la vallée du Rhône" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centre Hospitalier d'Ardeche Meridionale" #1 collaborator was "Hospices Civils de Lyon" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Centre Hospitalier d'Ardeche Meridionale" are "Colorectal Cancer" (3 trials), "Behavior Problem" (1 trials), "Blood Coagulation Factor Deficiencies" (1 trials), "Breast Cancer" (1 trials) and "Childbirth Problems" (1 trials). Many other conditions were trialed in "Centre Hospitalier d'Ardeche Meridionale" in a lesser frequency.

Most popular intervention types in "Centre Hospitalier d'Ardeche Meridionale" are "Drug" (3 trials), "Other" (2 trials), "Biological" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "CHEMOTHERAPY then HORMONOTHERAPY" (1 trials), "FOLFIRI regimen" (1 trials), "HORMONOTHERAPY" (1 trials), "Intensive Monitoring CEA" (1 trials) and "Intensive Monitoring Imagery" (1 trials). Other intervention names were less common.

The vast majority of trials in "Centre Hospitalier d'Ardeche Meridionale" are 6 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Centre Hospitalier d'Ardeche Meridionale". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Centre Hospitalier d'Ardeche Meridionale, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Centre Hospitalier d'Ardeche Meridionale, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".